FIGSFIGS Inc. shows a mixed profile with strong fundamental performance in profitability and balance sheet, but faces headwinds in growth and valuation. Thematic alignment is moderate. Technical indicators suggest a neutral to slightly bullish outlook.
FIGS operates in the healthcare apparel sector, which has steady demand but may not offer the high-growth potential of other tech-centric themes. Its direct-to-consumer model is a positive.
FIGS demonstrates strong profitability and a robust balance sheet with ample cash. However, recent revenue and net income growth have been negative, and the P/E ratio is very high relative to earnings.
The stock is trading within its 52-week range and shows mixed signals across different timeframes. While some moving averages suggest a buy, key oscillators indicate neutral to sell.
| Factor | Score |
|---|---|
| Healthcare Sector Growth | 60 |
| Direct-to-Consumer (DTC) Model | 70 |
| E-commerce and Digital Transformation | 50 |
| Supply Chain Resilience | 40 |
| Brand Loyalty and Community | 60 |
| Factor | Score |
|---|---|
| Valuation | 10 |
| Profitability | 30 |
| Growth | 20 |
| Balance Sheet Health | 85 |
| Cash Flow | 70 |
| Factor | Score |
|---|---|
| Trend Analysis | 60 |
| Momentum | 55 |
| Support & Resistance | 50 |
| Moving Averages | 50 |
Direct-to-Consumer Healthcare Apparel Leader
FIGS, Inc. is a well-established direct-to-consumer healthcare apparel and lifestyle company, recognized for its innovative scrubwear and related products. Its strong brand presence and digital-first approach position it well in a growing market.
Positive Short-Term Performance
The stock has shown positive performance across various short-term periods, including 5D (+7.63%), 1M (+11.51%), and 6M (+13.46%), indicating recent investor interest and positive momentum.
High P/E Ratio
The trailing Price-to-Earnings (P/E) ratio of 649.0 is exceptionally high, suggesting that the stock may be overvalued relative to its current earnings, demanding significant future growth to justify the valuation.
Low Net Margin
The net margin for Q4 2024 was 0.5%, indicating very thin profitability. While improving, this low margin suggests vulnerability to cost increases or sales fluctuations.
August 2025
8
Next Earnings Date
H: $0.03
A: $0.02
L: $0.01
H: 144.22M
A: 144.17M
L: 144.00M
FIGS, Inc., together with its subsidiary, FIGS Canada, Inc., operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. The company designs and sells scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel. It also offers sports bras, performance leggings and tops, super-soft pima cotton tops, vests, fleeces, and jackets; and necessities comprising scrub caps, lanyards, badge reels, tote bags, baseball caps, and beanies. The company markets and sells its products to healthcare professionals through its direct-to-consumer digital platform comprising website, mobile app, and B2B business, as well as retail stores. FIGS, Inc. was incorporated in 2013 and is headquartered in Santa Monica, California.
4.83 USD
The 39 analysts offering 1 year price forecasts for FIGS have a max estimate of 5.50 and a min estimate of 4.00.